from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3315c/cdd

LFCtreatmentdescriptionclass of inhibitor

0.993

Amikacinug/mL Amikacintranslation

-0.759

Cap5-10ug/mL Capreomycintranslation

-1.316

Rox10-50 ug/mL Roxithromycintranslation

0.462

SM2-5 ug/mL Streptomycintranslation

-1.081

Tet5-10 ug/mL Tetracyclinetranslation

1.849

Rif0.2-5ug/mL Rifampicintranscription

2.189

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.696

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.665

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.228

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.148

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.455

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.836

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.852

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.557

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.398

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.065

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.296

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.407

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.032

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.753

KCN5-20 ug/mL Potassium cyaniderespiration

0.461

NaN30.2-2 mM Sodium aziderespiration

-1.178

Nigericin50 uM Nigericinrespiration

0.241

TRC10-150 ug/mL Triclosanrespiration

0.517

TRZ10-25 ug/mL Thioridazinerespiration

-2.087

Valinomycin0.5-10 uM Valinomycinrespiration

-0.797

ZnSO42 mM ZnSO4respiration

-0.394

menadione6-10 ug/mL Menadionerespiration

-0.504

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.967

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.335

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.526

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.618

NRP_1Non-replicating persistence stage 1dosRassociated

0.596

Amp0.2mg/mL AmpicillincellWall

-0.652

Cephalexin20-100 ug/mL CephalexincellWall

-0.503

Cerulenin0.32-5 ug/mL CerulenincellWall

1.660

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.777

EMB10-20 ug/mL EthambutolcellWall

0.508

Eta12-40 ug/mL EthionamidecellWall

0.164

INH0.2-0.4 ug/mL IsoniazidcellWall

0.588

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.693

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.197

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.042

BZA0.12 mg/mL BenzamidearomaticAmides

0.238

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.146

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.110

H2O24 mM hydrogen peroxideDNAdamaging

1.215

Levo10 ug/mL LevofloxacinDNAdamaging

0.060

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.417

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.994

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.452

UVUV-irradiationDNAdamaging

0.002

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.167

Antimycin12.5-50 ug/mL Antimycin A?

-0.651

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.411

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.332

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.853

PA8240.2-2 ug/mL PA-824?

-0.121

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.265

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.740

Verapamil50 uM Verapamil?

-0.289

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.373

methoxatin10-20 ug/mL Methoxatin?